SCHEMBL12467229

SCHEMBL12467229

CCCC(c1ccc(F)c(Cl)c1)c1nc(N)c2cc(-c3ccc(F)cc3)sc2n1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.38
ADORA1 P30542 4/20 0.38
RPS6KB1 P23443 2/20 0.34
FDPS P14324 1/20 0.33
PIK3CA P42336 1/20 0.32
FGFR1 P11362 1/20 0.31
EPHB4 P54760 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
EGFR P00533 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1693676 0.77 ADORA2A (0.56) ADORA2AADORA1EPHB4
SCHEMBL794555 0.73 ADORA2A (0.40) ADORA2AADORA1PIK3CAMAPTSMN1; SMN2
SCHEMBL656145 0.64 FGFR1 (0.56) FGFR1EGFR
SCHEMBL654609 0.61 FGFR1 (0.47) ADORA2AADORA1PIK3CAFGFR1KDM4E
SCHEMBL653492 0.61 CSNK2A1 (0.48) FGFR1EGFR
SCHEMBL655418 0.61 PIK3CA (0.45) ADORA2AADORA1PIK3CAFGFR1KDM4E
SCHEMBL13126260 0.60 SLC6A2 (0.48) KDM4ENPC1RAB9ASMN1; SMN2MEN1
SCHEMBL656557 0.60 FGFR1 (0.69) FGFR1EGFR
SCHEMBL16953382 0.59 SLC6A2 (0.43) KDM4ENPC1MAPTRAB9ASMN1; SMN2
SCHEMBL27472082 0.59 SLC6A2 (0.40) KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-07-24 EP disclosed
EP-2575969-A1 ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2013-04-10 EP disclosed
WO-2012035423-A1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-03-22 WO disclosed